408 results on '"Tullis E"'
Search Results
2. 708 Outcomes after liver transplantation in people with cystic fibrosis: systematic review and meta-analysis
3. 709 Randomized, double-blind, placebo-controlled trial of oral prednisone as adjunctive treatment in pulmonary exacerbations in cystic fibrosis (PIPE Study)
4. 619 Changing demographic characteristics of individuals with cystic fibrosis transitioning from pediatric to adult care
5. 605 Description of sleep breathing disorder prevalence, risk factors, and treatment in adults with cystic fibrosis
6. 710 Real-world impact of elexacaftor-tezacaftor-ivacaftor on quality of life of adults with cystic fibrosis
7. 554 Mucosal inflammation of the colon and terminal ileum in peoplewith cystic fibrosis is mild and not associated with abdominal pain or presence of polyps
8. EPS6.05 A phase 3b study of the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on cough and physical activity in people with cystic fibrosis (CF)
9. WS05.03 A phase 3b study of the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on glucose tolerance in people with cystic fibrosis (CF) and abnormal glucose metabolism
10. AB1850 MICROSCOPIC POLYANGIITIS WITH CONCURRENT THROMBOTIC THROMBOCYTOPENIC PURPURA: A CASE REPORT
11. Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women
12. 170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study
13. 492 Effect of antibiotic changes during treatment of cystic fibrosis pulmonary exacerbations
14. Prognostic relevance of dynamic hyperinflation during cardiopulmonary exercise testing in adult patients with cystic fibrosis
15. A randomized controlled trial of inhaled l-Arginine in patients with cystic fibrosis
16. Recommendations for the classification of diseases as CFTR-related disorders
17. 37: The impact of chronic rhinosinusitis on the health-related quality of life among adult patients with cystic fibrosis
18. 286: Fertility and fatherhood in men with CF
19. 289: Fatherhood in men with cystic fibrosis: A survey of the knowledge, opinions, and experiences regarding family planning
20. 5: Testosterone deficiency in men with cystic fibrosis: Understanding prevalence & association with clinical outcomes
21. Does the Macroduct ® collection system reliably define sweat chloride concentration in subjects with intermediate results?
22. A Phase 3 open-label study of ELX/TEZ/IVA in children 6 through 11 years of age with CF and at least one F508del allele
23. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
24. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants
25. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas
26. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe
27. INTEGRATING BEST PRACTICES FOR SMOKING CESSATION INTO THE UNIT NURSEʼS ROLE: 601
28. ESTABLISHING THERAPEUTIC RELATIONSHIP BETWEEN NURSES AND PATIENTS TO REDUCE ANXIETY AND FEAR DURING HOSPITALIZATION: 606
29. TELEMEDICINE TO IMPROVE ACCESS TO SPECIALIZED CARE FOR PATIENTS WITH CYSTIC FIBROSIS: 605
30. CYSTIC FIBROSIS AND OVARIAN RESERVE: 542★
31. A WEIGHTY PROBLEM: THE PREVALENCE OF OVERWEIGHT AND OBESE ADULTS WITH CYSTIC FIBROSIS OVER TIME: 521
32. A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF CHOLECALCIFEROL FOR VITAMIN D DEFICIENCY IN ADULTS WITH CYSTIC FIBROSIS: 515
33. DYNAMIC HYPERINFLATION DURING CARDIOPULMONARY EXERCISE TESTING IN CYSTIC FIBROSIS: 404★
34. FACTORS INFLUENCING TIME TO FIRST ACQUISITION OF STENOTROPHOMONAS MALTOPHILIA INFECTION IN CYSTIC FIBROSIS PATIENTS: 325
35. THE EFFECT OF BURKHOLDERIA COLONY MORPHOLOGY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES IN A RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI): 307
36. LUNG FUNCTION IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA (BURK) SPECIES INFECTION OVER THE COURSE OF A PROSPECTIVE, RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI): 310
37. IS CHRONIC STENOTROPHOMONAS MALTOPHILIA INFECTION ASSOCIATED WITH MORTALITY OR LUNG TRANSPLANTATION IN CYSTIC FIBROSIS PATIENTS?: 281
38. Cystic fibrosis and ovarian reserve: O-201
39. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis*
40. IMPROVING COMPLIANCE WITH HAND HYGIENE: “SHOW & TELL”: 574★
41. END OF LIFE AND THE AFTER-DEATH BEREAVEMENT PROCESS IN A LARGE ADULT CYSTIC FIBROSIS CENTRE: 555
42. SPINK1 MUTATION N34S INCREASES RISK OF PANCREATITIS IN PATIENTS WITH CF AND CFTR-RELATED DISORDERS: 489★
43. EVALUATION OF IN-HOSPITAL MEAL SERVICE: GAPS IN CARE TRANSLATE INTO GAPS IN WEIGHT GAIN: 458
44. THE CONTRIBUTION OF PULMONARY EXACERBATIONS TO LUNG FUNCTION DECLINE IN CYSTIC FIBROSIS PATIENTS: 336★
45. DOES CHRONIC STENOTROPHOMONAS MALTOPHILIA INFECTION AFFECT CLINICAL OUTCOME FOLLOWING PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS?: 252★
46. EFFECTS OF CONTINUOUS AZTREONAM FOR INHALATION SOLUTION (AZLI) USE ON PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES INFECTION: 257★
47. AZTREONAM FOR INHALATION SOLUTION (AZLI) IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES (BURK) INFECTION: INITIAL RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL: 234
48. A RANDOMIZED PLACEBO CONTROLLED STUDY ON THE EFFECTS OF L-ARGININE INHALATION IN PATIENTS WITH CYSTIC FIBROSIS: 229
49. VALIDATION OF SWEAT GLAND POTENTIAL DIFFERENCE MEASUREMENTS AS A PRACTICAL IN VIVO METHOD OF ASSESSING CFTR FUNCTION: 213
50. Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.